Early research (Phase 1)Active Not RecruitingNCT05698017
What this trial is testing
Study to Evaluate Investigational Allogeneic Cell Therapy Product hOMSC300 for Treatment of Early to Moderate Stage Multiple System Atrophy (MSA)
Who this might be right for
Multiple System AtrophyMSA - Multiple System Atrophy
Cytora Ltd. 10